Shuttle Pharmaceuticals Holdings Total Debt Growth & History (SHPH)
Shuttle Pharmaceuticals Holdings's total debt was $232,147 for fiscal 2025.
View full Shuttle Pharmaceuticals Holdings company overviewShuttle Pharmaceuticals Holdings annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $232,147 | −$66,850 | −22.36% |
| 2024 | 2024-12-31 | $298,997 | −$653,608 | −68.61% |
| 2023 | 2023-12-31 | $952,605 | $889,782 | +1416.33% |
| 2022 | 2022-12-31 | $62,823 | −$157,574 | −71.50% |
| 2021 | 2021-12-31 | $220,397 | — | — |
Shuttle Pharmaceuticals Holdings quarterly total debt
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $214,013 | −$69,323 | −24.47% |
| Q4 2025 | 2025-12-31 | $232,147 | −$66,850 | −22.36% |
| Q3 2025 | 2025-09-30 | $249,815 | −$64,442 | −20.51% |
| Q2 2025 | 2025-06-30 | $267,028 | −$888,324 | −76.89% |
| Q1 2025 | 2025-03-31 | $283,336 | −$1.0M | −77.94% |
| Q4 2024 | 2024-12-31 | $298,997 | −$653,608 | −68.61% |
| Q3 2024 | 2024-09-30 | $314,257 | −$652,409 | −67.49% |
| Q2 2024 | 2024-06-30 | $1.2M | $373,838 | +47.84% |
| Q1 2024 | 2024-03-31 | $1.3M | $1.2M | +2778.03% |
| Q4 2023 | 2023-12-31 | $952,605 | $889,782 | +1416.33% |
| Q3 2023 | 2023-09-30 | $966,666 | $886,288 | +1102.65% |
| Q2 2023 | 2023-06-30 | $781,514 | — | — |
| Q1 2023 | 2023-03-31 | $44,633 | — | — |
| Q4 2022 | 2022-12-31 | $62,823 | −$157,574 | −71.50% |
| Q3 2022 | 2022-09-30 | $80,378 | — | — |
| Q4 2021 | 2021-12-31 | $220,397 | — | — |
Shuttle Pharmaceuticals Holdings total debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Shuttle Pharmaceuticals Holdings's total debt increased from $220,397 to $232,147, a change of $11,750. The latest reported quarter, Q1 2026, shows $214,013.
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Shuttle Pharmaceuticals Holdings source filings ↗